Early ID of Postpartum Hemorrhage Helpful in Vaginal Delivery
FRIDAY, May 12, 2023 (HealthDay News) — For patients having a vaginal delivery, early detection of postpartum hemorrhage and use of bundled treatment leads to a reduction in a composite of severe postpartum hemorrhage, laparotomy for bleeding, or dea…
Learn MoreArtificial Intelligence Improves Prediction of Pancreatic Cancer
FRIDAY, May 12, 2023 (HealthDay News) — Artificial intelligence (AI) can improve the design of surveillance programs for pancreatic cancer, according to a study published online May 8 in Nature Medicine.Davide Placido, from the University of Copenhag…
Learn MoreIntra-Op Liposomal Bupivacaine Beneficial After Spinal Fusion in Scoliosis
FRIDAY, May 12, 2023 (HealthDay News) — For adolescent idiopathic scoliosis (AIS) patients undergoing posterior spinal fusion (PSF), intraoperative liposomal bupivacaine (LB) infiltration is associated with lower total opioid consumption and shorter …
Learn MoreFDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks
FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.Although most of the Pulmonary-Allergy D…
Learn MoreHomozygous Familial Hypercholesterolemia Has Variable Presentation
FRIDAY, May 12, 2023 (HealthDay News) — Homozygous familial hypercholesterolemia (HoFH) is a severe disorder with a variable clinical presentation, which appears to be systematically underdiagnosed and undertreated, according to a study published onl…
Learn MoreLess Slow-Wave Sleep, Severe OSA Linked to White Matter Abnormalities
FRIDAY, May 12, 2023 (HealthDay News) — Older adults with obstructive sleep apnea (OSA) who spend less time in slow-wave sleep have a higher burden of white matter abnormalities, according to a study published online May 10 in Neurology.Diego Z. Carv…
Learn MoreAddition of GLP1-RA Tied to Lower MACE, Heart Failure Risk in Those With Diabetes
FRIDAY, May 12, 2023 (HealthDay News) — For individuals with diabetes without preexisting cardiovascular disease, the addition of glucagon-like peptide 1 receptor agonists (GLP1-RA) is associated with a lower risk for major adverse cardiac events (MA…
Learn More